
Lexaria Bioscience Corp.
LEXXNASDAQHealthcare● Active
$0.65
+$0.01(+1.51%)
Market Cap$13219377
P/E Ratio—
52W High$1.55
52W Low$0.46
Lexaria Bioscience Corp.(LEXX)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · LEXX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-08 | 2024-08 | 2023-08 | 2022-08 | 2021-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.71M | $0.46M | $0.23M | $0.26M | $0.72M |
| Cost of Revenue | $0.00M | $0.00M | $0.03M | $0.07M | $0.18M |
| Gross Profit | $0.70M | $0.46M | $0.19M | $0.18M | $0.55M |
| Gross Margin %(computed) | 99.61% | 98.96% | 86.07% | 71.87% | 75.74% |
| Operating Expenses | |||||
| R&D Expenses | $8.24M | $2.36M | $3.67M | $1.84M | $1.26M |
| G&A Expenses | $4.35M | $3.85M | $3.06M | $4.96M | $4.97M |
| Total Operating Expenses | $12.58M | $6.21M | $6.73M | $6.80M | $6.23M |
| Operating Income | ($11.88M) | ($5.75M) | ($6.53M) | ($6.62M) | ($5.69M) |
| Operating Margin %(computed) | — | — | — | — | -786.85% |
| Interest Income | $0.00M | $0.01M | $0.04M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($11.91M) | ($5.81M) | ($6.71M) | ($7.38M) | ($4.16M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($11.90M) | ($5.80M) | ($6.66M) | ($7.27M) | ($4.03M) |
| Net Margin %(computed) | — | — | — | — | -557.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.66 | $-0.47 | $-1.01 | $-1.24 | $-0.92 |
| Wtd Avg Shares | 18.00M | 12.38M | 6.61M | 5.89M | 4.39M |
| EBITDA | ($11.79M) | ($5.68M) | ($6.39M) | ($6.52M) | ($5.54M) |
| EBITDA Margin %(computed) | — | — | — | — | -766.43% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M
深入了解Lexaria Bioscience Corp.
关于Lexaria Bioscience Corp.(LEXX)损益表
Lexaria Bioscience Corp.(LEXX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LEXX实现营收$0.00B,毛利润$0.00B(毛利率99.61%),净利润($0.01B)(净利率-1686.00%)。
常见问题
LEXX · 4 问Lexaria Bioscience Corp.(LEXX)2025财年营收为$0.00B,同比up52.0%。
LEXX revenueLEXX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09